Clinical characteristics and survival of esophageal cancer patients: annual report of the surgical treatment in Shanghai Chest Hospital, 2017.

Chang Yuan Xiaolu Wu Yuxin YangZhichao LiuYifeng SunXufeng GuoBin LiRong HuaYang YangTeng MaoHong ZhangYuchen SuChunguang LiShan-Shan Geng Zhi-Gang Li

Published in: Journal of thoracic disease (2024)

The 5-year OS of patients with esophageal cancer can reach 52.5% after surgical treatment in 2017 at SCH. The exact beneficiaries of neoadjuvant therapy are still unclear in the 2017 cohort.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
peritoneal dialysis
lymph node
prognostic factors
squamous cell carcinoma
stem cells
locally advanced
density functional theory
bone marrow
adverse drug
cell therapy